Diabetic nephropathy

Mark E. Molitch, Ralph A. DeFronzo, Marion J. Franz, William F. Keane, Carl Erik Mogensen, Hans Henrik Parving, Michael W. Steffes

Research output: Contribution to journalReview article

202 Scopus citations

Abstract

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Original languageEnglish (US)
Pages (from-to)S85-S89
JournalDiabetes care
Volume25
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 2002

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Diabetic nephropathy'. Together they form a unique fingerprint.

  • Cite this

    Molitch, M. E., DeFronzo, R. A., Franz, M. J., Keane, W. F., Mogensen, C. E., Parving, H. H., & Steffes, M. W. (2002). Diabetic nephropathy. Diabetes care, 25(SUPPL. 1), S85-S89. https://doi.org/10.2337/diacare.25.2007.s85